Search
- Home
- Shop All Products
- Genexus Integrated Sequencer Assays
Ion AmpliSeq™ SARS-CoV-2 Insight Research Assay GX
The Ion AmpliSeq SARS-CoV-2 Insight Research Assay GX is a quick, accurate, and comprehensive next-generation sequencing (NGS) assay to enable research and surveillance of the SARS-CoV-2 virus, including variants of concern, through complete genome sequencing.
Oncomine™ Myeloid RNA Assay GX v2
A comprehensive targeted next-generation sequencing (NGS) assay designed for sensitive detection of myeloid disorder-associated RNA fusion transcripts in blood and bone marrow samples. This assay is the RNA component of the Oncomine™ Myeloid Assay GX V2 (A50694), which includes both DNA and RNA...
Oncomine™ Myeloid Assay GX v2
A comprehensive targeted next-generation sequencing (NGS) assay designed for sensitive detection of myeloid disorder-associated DNA mutations and RNA fusion transcripts in blood and bone marrow samples.
Ion ReproSeq™ PGT-A GX5 Kit
Experience the convenience of all-in-one template preparation and sequencing, streamlining your PGT-A workflow and reducing hands-on time with load-and-go functionality and user-friendly software.
Ion AmpliSeq™ Polyploidy Panel Kit with Ion GX5™ Chips (384 Samples)
The Genexus System-compatible Ion AmpliSeq Polyploidy Panel Kit empowers accurate quality controls in preimplantation genetic testing for aneuploidy (PGT-A) by leveraging SNP-based assessments.
Oncomine™ BRCA Assay GX
The Oncomine BRCA Assay GX is a targeted next-generation sequencing (NGS) assay designed to provide comprehensive amplification of all coding regions of the human BRCA1 and BRCA2 genes, enabling accurate and sensitive detection of various mutation classes.
Ion AmpliSeq™ Microbiome Health Research Assay GX
The Ion AmpliSeq Microbiome Health Research Assay Gx is a targeted next-generation sequencing (NGS) assay for characterization of the human gut microbiome, which has been implicated in human disease.
Oncomine™ Myeloid DNA Assay GX v2
A comprehensive targeted next-generation sequencing (NGS) assay designed for sensitive detection of myeloid disorder-associated DNA mutations in blood and bone marrow samples. This assay is the DNA component of the Oncomine™ Myeloid Assay GX V2 (A50694), which includes both DNA and RNA assays.
